Pandemic-induced social isolation: Assessing its impact on older adults’ wellbeing

Ar­genx is tak­ing a page from its own com­mer­cial­iza­tion play­book with a new rare dis­ease cam­paign. The un­brand­ed “Shin­ing through CIDP” cam­paign show­cas­es re­al sto­ries

HitGen’s OpenDEL platform can be used for running affinity screening experiments against protein targets. Credit: Gorodenkoff/Shutterstock.com. Chinese company HitGen and the Structural Genomics Consortium (SGC)